Marzena Swojnóg
Marzena Swojnóg has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Dominika Bieszczad
Medical University of Lublin, Lublin, Poland
12 shared publications - Magdalena Barczewska
Medical University of Lublin, Lublin, Poland
12 shared publications - Adam Mazurek
Https://orcid.org Central Clinical Hospital in Łódź https://orcid 9058-0868 Kinga Popielarska Private practice 7797-5301 Marta Opalińska-Kubowicz https://orcid.org/ Zuzanna Musialska https://orcid.org 7916-614X Yuliia Protsenko https://orcid.org/ Marta Kowalska https://orcid.org/ Magdalena Barczewska https://orcid.org 1990-6096 Anna Marczak https://orcid.org/ Dominika Bieszczad https://orcid.org 0009-0005-1475 Gdańsk -617X Marzena Swojnóg Poland
7 shared publications - Anna Marczak
Private Practice, Gdańsk, Poland
7 shared publications - Kinga Popielarska
Medical University of Gdansk, Gdansk, Poland
7 shared publications - Marta Kowalska
University Hospital of Cracow, Cracow, Poland
7 shared publications
Latest Publications
- Open Access
- 24 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (1(49))
DIGITAL DEMENTIA IN CHILDREN AND ADOLESCENTS: SYMPTOMS, RISK FACTORS AND PREVENTION STRATEGIES. A NARRATIVE REVIEW
Children and adolescents, as the new generation of avid technology users, are often able to use it to their great benefit. However, it comes with the cost of being exposed to a variety of health risks, cognitive health being one of the main areas affected. As developing brains are the most susceptible to these risks, Manfred Spitzer’s concept of digital dementia seems as relevant as ever nowadays. In the present study, we analyse over a hundred published works with the goal of creating a compact yet comprehensive summary of existing knowledge on digital dementia in the population of infants, preschoolers, schoolchildren and adolescents. Findings suggest that multiple cognition areas are affected, with memory, critical thinking and problem solving being among the most alarming. While the role of parents as guardians of digital health cannot be overstated, other factors such as environment and unmodifiable traits also play a role. For preventing and mitigating this problem, a collaborative effort of caretakers but also teachers, doctors and policy makers is most urgently needed. We conclude that digital dementia among youth is a common problem, therefore recognising symptoms early, minimising risks and preventing its progression will prove beneficial to whole generations.
- 24 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 5 (1(49))
Open AccessDIGITAL DEMENTIA IN CHILDREN AND ADOLESCENTS: SYMPTOMS, RISK FACTORS AND PREVENTION STRATEGIES. A NARRATIVE REVIEW
Children and adolescents, as the new generation of avid technology users, are often able to use it to their great benefit. However, it comes with the cost of being exposed to a variety of health risks, cognitive health being one of the main areas affected. As developing brains are the most susceptible to these risks, Manfred Spitzer’s concept of digital dementia seems as relevant as ever nowadays. In the present study, we analyse over a hundred published works with the goal of creating a compact yet comprehensive summary of existing knowledge on digital dementia in the population of infants, preschoolers, schoolchildren and adolescents. Findings suggest that multiple cognition areas are affected, with memory, critical thinking and problem solving being among the most alarming. While the role of parents as guardians of digital health cannot be overstated, other factors such as environment and unmodifiable traits also play a role. For preventing and mitigating this problem, a collaborative effort of caretakers but also teachers, doctors and policy makers is most urgently needed. We conclude that digital dementia among youth is a common problem, therefore recognising symptoms early, minimising risks and preventing its progression will prove beneficial to whole generations.
- Open Access
- 23 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
SHRINKING LUNG SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS-CLINICAL AND THERAPEUTIC CHALLENGES
Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. One of its rare but clinically significant complications is the shrinking lung syndrome (SLS), which affects less than 1% of patients and presents diagnostic and therapeutic challenges. Aim: This paper aims to present a comprehensive overview of shrinking lung syndrome as a rare manifestation of SLE, with a focus on its pathophysiology, diagnostic difficulties, and current therapeutic approaches. Materials and Methods: A narrative review was conducted based on selected scientific publications indexed in PubMed, Scopus, and Google Scholar. The inclusion criteria included articles describing the pathophysiology, clinical features, diagnosis, and treatment of SLS in the context of SLE. Results: SLS is characterized by progressive dyspnea, diaphragmatic elevation, and restrictive defects on pulmonary function testing. The exact pathogenesis remains unclear but involves neuromuscular dysfunction, diaphragmatic weakness, pleural involvement, and potential autoantibody-mediated mechanisms. Diagnosis is challenging due to the absence of specific markers and requires exclusion of other causes. Treatment primarily includes corticosteroids and immunosuppressants, with adjunctive respiratory rehabilitation. Despite therapy, pulmonary restriction may persist. Conclusions: SLS remains an under-recognized and underdiagnosed complication of SLE. Increased clinical awareness and early diagnostic interventions are key to preventing long-term respiratory impairment. Future research is needed to establish standardized diagnostic protocols and treatment guidelines.
- 23 March 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (1(49))
Open AccessSHRINKING LUNG SYNDROME IN SYSTEMIC LUPUS ERYTHEMATOSUS-CLINICAL AND THERAPEUTIC CHALLENGES
Background: Systemic lupus erythematosus (SLE) is a chronic autoimmune disease characterized by multisystem involvement. One of its rare but clinically significant complications is the shrinking lung syndrome (SLS), which affects less than 1% of patients and presents diagnostic and therapeutic challenges. Aim: This paper aims to present a comprehensive overview of shrinking lung syndrome as a rare manifestation of SLE, with a focus on its pathophysiology, diagnostic difficulties, and current therapeutic approaches. Materials and Methods: A narrative review was conducted based on selected scientific publications indexed in PubMed, Scopus, and Google Scholar. The inclusion criteria included articles describing the pathophysiology, clinical features, diagnosis, and treatment of SLS in the context of SLE. Results: SLS is characterized by progressive dyspnea, diaphragmatic elevation, and restrictive defects on pulmonary function testing. The exact pathogenesis remains unclear but involves neuromuscular dysfunction, diaphragmatic weakness, pleural involvement, and potential autoantibody-mediated mechanisms. Diagnosis is challenging due to the absence of specific markers and requires exclusion of other causes. Treatment primarily includes corticosteroids and immunosuppressants, with adjunctive respiratory rehabilitation. Despite therapy, pulmonary restriction may persist. Conclusions: SLS remains an under-recognized and underdiagnosed complication of SLE. Increased clinical awareness and early diagnostic interventions are key to preventing long-term respiratory impairment. Future research is needed to establish standardized diagnostic protocols and treatment guidelines.
- Open Access
- 27 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
INTERVENTIONS TARGETING IMPAIRED FASTING GLUCOSE: A COMPREHENSIVE REVIEW OF STRATEGIES TO PREVENT TYPE 2 DIABETES
Objective: Impaired Fasting Glucose (IFG), a state of prediabetes characterized by elevated fasting glucose levels, signifies a significantly increased risk of developing Type 2 Diabetes Mellitus (T2D) and associated cardiovascular complications. This comprehensive review systematically analyzes evidence from original research, including Randomized Controlled Trials (RCTs), prospective and retrospective cohort studies, and single- and multi-center implementation experiences, to evaluate the effectiveness and translation challenges of interventions targeting IFG progression. Methods: A targeted literature search was conducted across major medical databases, focusing on human intervention studies published between 2000 and 2025. Included articles were categorized based on intervention type (Intensive Lifestyle Intervention [ILI] or pharmacological) and study design, with an emphasis on T2D incidence rate reduction as the primary outcome. Key Findings: The analysis confirms that ILI, focused on diet, physical activity, and achieving moderate weight loss (5–7%), remains the most efficacious long-term strategy, demonstrating superior and sustained T2D risk reduction (e.g., 58% in the Diabetes Prevention Program) (Diabetes Prevention Program Research Group, 2002); (Tuomilehto et al., 2001). Metformin therapy serves as a critical, cost-effective pharmacological alternative, particularly for high-risk subgroups (e.g., younger individuals, high BMI). Translational studies, including retrospective and multi-center experiences, highlight significant barriers to real-world implementation, such as low sustained adherence and scalability challenges within diverse populations. Conclusion: Effective T2D prevention in individuals with IFG necessitates early, risk-stratified intervention. While ILI is the gold standard, future strategies must focus on developing tailored, technologically-supported, and scalable programs to overcome implementation barriers and maximize population-level health impact.
- 27 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
Open AccessINTERVENTIONS TARGETING IMPAIRED FASTING GLUCOSE: A COMPREHENSIVE REVIEW OF STRATEGIES TO PREVENT TYPE 2 DIABETES
Objective: Impaired Fasting Glucose (IFG), a state of prediabetes characterized by elevated fasting glucose levels, signifies a significantly increased risk of developing Type 2 Diabetes Mellitus (T2D) and associated cardiovascular complications. This comprehensive review systematically analyzes evidence from original research, including Randomized Controlled Trials (RCTs), prospective and retrospective cohort studies, and single- and multi-center implementation experiences, to evaluate the effectiveness and translation challenges of interventions targeting IFG progression. Methods: A targeted literature search was conducted across major medical databases, focusing on human intervention studies published between 2000 and 2025. Included articles were categorized based on intervention type (Intensive Lifestyle Intervention [ILI] or pharmacological) and study design, with an emphasis on T2D incidence rate reduction as the primary outcome. Key Findings: The analysis confirms that ILI, focused on diet, physical activity, and achieving moderate weight loss (5–7%), remains the most efficacious long-term strategy, demonstrating superior and sustained T2D risk reduction (e.g., 58% in the Diabetes Prevention Program) (Diabetes Prevention Program Research Group, 2002); (Tuomilehto et al., 2001). Metformin therapy serves as a critical, cost-effective pharmacological alternative, particularly for high-risk subgroups (e.g., younger individuals, high BMI). Translational studies, including retrospective and multi-center experiences, highlight significant barriers to real-world implementation, such as low sustained adherence and scalability challenges within diverse populations. Conclusion: Effective T2D prevention in individuals with IFG necessitates early, risk-stratified intervention. While ILI is the gold standard, future strategies must focus on developing tailored, technologically-supported, and scalable programs to overcome implementation barriers and maximize population-level health impact.
- Open Access
- 27 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
INNOVATIVE TECHNOLOGIES IN THE DIAGNOSIS AND TREATMENT OF INFERTILITY: A COMPREHENSIVE REVIEW
Infertility is increasingly recognized as a condition affecting diverse populations and one that requires advanced medical and technological approaches to support effective diagnosis and treatment. In recent years, significant progress in medical sciences and digital technologies has refined the ways infertility is assessed and managed. Contemporary diagnostic methods now include high-resolution imaging, hormonal and genetic testing, microbiome evaluation, and immunological analysis. These advancements enable clinicians to identify reproductive disorders with greater precision. Artificial intelligence (AI) and robotic systems further support clinical decision-making by improving embryo selection, predicting treatment outcomes, and standardizing laboratory procedures. Advances in assisted reproductive technologies (ART) have expanded therapeutic options for patients who previously had limited chances of achieving pregnancy. Although technology plays a crucial role in modern infertility care, patient experiences and psychological well-being remain equally important, as treatment can be both emotionally and physically demanding. This review summarizes current knowledge on innovative technologies used in the diagnosis and treatment of infertility and highlights how the continued development of these methods enhances clinical outcomes and patient care.
- 27 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
Open AccessINNOVATIVE TECHNOLOGIES IN THE DIAGNOSIS AND TREATMENT OF INFERTILITY: A COMPREHENSIVE REVIEW
Infertility is increasingly recognized as a condition affecting diverse populations and one that requires advanced medical and technological approaches to support effective diagnosis and treatment. In recent years, significant progress in medical sciences and digital technologies has refined the ways infertility is assessed and managed. Contemporary diagnostic methods now include high-resolution imaging, hormonal and genetic testing, microbiome evaluation, and immunological analysis. These advancements enable clinicians to identify reproductive disorders with greater precision. Artificial intelligence (AI) and robotic systems further support clinical decision-making by improving embryo selection, predicting treatment outcomes, and standardizing laboratory procedures. Advances in assisted reproductive technologies (ART) have expanded therapeutic options for patients who previously had limited chances of achieving pregnancy. Although technology plays a crucial role in modern infertility care, patient experiences and psychological well-being remain equally important, as treatment can be both emotionally and physically demanding. This review summarizes current knowledge on innovative technologies used in the diagnosis and treatment of infertility and highlights how the continued development of these methods enhances clinical outcomes and patient care.
- Open Access
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Comprehensive Analysis of Therapeutic Strategies for Mycoplasma pneumoniae Infections: A Global and European Review of Current Antibiotic Treatment Standards in Paediatric and Adult Populations in an Era of Increasing Antimicrobial Resistance
Background.Mycoplasma pneumoniae infections remain a significant clinical challenge, particularly in the paediatric population, where they constitute a common cause of community-acquired pneumonia (CAP). The absence of a cell wall results in intrinsic resistance to beta-lactam antibiotics, necessitating the use of antimicrobials targeting intracellular processes. In the post-pandemic period, a resurgence of M. pneumoniae infections has been observed, partly attributed to an “immunity gap” following non-pharmaceutical interventions. At the same time, macrolide-resistant M. pneumoniae (MRMP) has become an increasing concern, especially in Asia and increasingly in Europe, significantly influencing therapeutic strategies. Aim.To review current antibiotic treatment standards for Mycoplasma pneumoniae infections in children and adults, with particular emphasis on macrolide resistance, regional epidemiology, and practical clinical management of CAP of suspected mycoplasmal aetiology. Material and methods.This narrative review analysed contemporary literature published primarily between 2010 and 2025. Data sources included clinical guidelines for CAP in adults and children, systematic reviews and meta-analyses on MRMP, primary studies on resistance mechanisms (23S rRNA mutations, L4/L22 alterations, resistance emergence during therapy), and studies evaluating doxycycline safety in children. Peer-reviewed articles indexed in PubMed and PubMed Central were included. The synthesis was structured according to patient age, disease severity, geographical region, and therapeutic decision pathways. Results.Available evidence indicates increasing global prevalence of MRMP, with marked regional differences. Macrolides remain first-line therapy in many settings; however, treatment failure rates are higher in regions with elevated resistance. Doxycycline and fluoroquinolones represent effective alternatives, with growing evidence supporting doxycycline safety in paediatric populations. Escalation of therapy after 48–72 hours of non-response is a key component of effective management, particularly in severe or refractory cases. Conclusions.Mycoplasma pneumoniae remains a major cause of CAP in both children and adults. Rising macrolide resistance necessitates region-specific treatment strategies, careful clinical reassessment, and judicious antibiotic selection. Updated management algorithms incorporating resistance patterns and timely therapy escalation are essential to optimise outcomes and support antibiotic stewardship.
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Open AccessComprehensive Analysis of Therapeutic Strategies for Mycoplasma pneumoniae Infections: A Global and European Review of Current Antibiotic Treatment Standards in Paediatric and Adult Populations in an Era of Increasing Antimicrobial Resistance
Background.Mycoplasma pneumoniae infections remain a significant clinical challenge, particularly in the paediatric population, where they constitute a common cause of community-acquired pneumonia (CAP). The absence of a cell wall results in intrinsic resistance to beta-lactam antibiotics, necessitating the use of antimicrobials targeting intracellular processes. In the post-pandemic period, a resurgence of M. pneumoniae infections has been observed, partly attributed to an “immunity gap” following non-pharmaceutical interventions. At the same time, macrolide-resistant M. pneumoniae (MRMP) has become an increasing concern, especially in Asia and increasingly in Europe, significantly influencing therapeutic strategies. Aim.To review current antibiotic treatment standards for Mycoplasma pneumoniae infections in children and adults, with particular emphasis on macrolide resistance, regional epidemiology, and practical clinical management of CAP of suspected mycoplasmal aetiology. Material and methods.This narrative review analysed contemporary literature published primarily between 2010 and 2025. Data sources included clinical guidelines for CAP in adults and children, systematic reviews and meta-analyses on MRMP, primary studies on resistance mechanisms (23S rRNA mutations, L4/L22 alterations, resistance emergence during therapy), and studies evaluating doxycycline safety in children. Peer-reviewed articles indexed in PubMed and PubMed Central were included. The synthesis was structured according to patient age, disease severity, geographical region, and therapeutic decision pathways. Results.Available evidence indicates increasing global prevalence of MRMP, with marked regional differences. Macrolides remain first-line therapy in many settings; however, treatment failure rates are higher in regions with elevated resistance. Doxycycline and fluoroquinolones represent effective alternatives, with growing evidence supporting doxycycline safety in paediatric populations. Escalation of therapy after 48–72 hours of non-response is a key component of effective management, particularly in severe or refractory cases. Conclusions.Mycoplasma pneumoniae remains a major cause of CAP in both children and adults. Rising macrolide resistance necessitates region-specific treatment strategies, careful clinical reassessment, and judicious antibiotic selection. Updated management algorithms incorporating resistance patterns and timely therapy escalation are essential to optimise outcomes and support antibiotic stewardship.
- Open Access
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Non-Suicidal Self-Injury (NSSI) in Borderline Personality Disorder: Dynamic Mechanisms, Cascading Models, and Psychosocial Outcomes in the Context of Specialist Interventions
Background. Non-suicidal self-injury (NSSI) occurs in 69-90% of women with borderline personality disorder (BPD) and represents a critical diagnostic criterion and therapeutic challenge. Despite its high prevalence and clinical significance, the dynamic psychological and neurobiological mechanisms underlying NSSI remain incompletely understood, and a substantial gap persists between acute symptom reduction and long-term psychosocial recovery. Aim. This study reviews NSSI in BPD, focusing on: identification of proximal psychological mechanisms and developmental factors influencing NSSI risk, and assessment of specialized therapeutic approaches' effectiveness in reducing NSSI and achieving sustained psychosocial functioning. Materials and Methods. A literature review was conducted using databases (PubMed, PsycINFO, and Google Scholar) for articles up to November 2025. Inclusion criteria focused on peer-reviewed studies examining NSSI in BPD populations using validated assessment tools. Results. Neuroimaging demonstrates that NSSI produces immediate amygdala deactivation, providing neurobiological reinforcement for this behavior. The Emotional Cascade Model identifies rumination instability and emotion differentiation deficits as key triggers for NSSI episodes. Childhood trauma dysregulates the HPA axis and correlates with functional deficits. Dialectical Behavior Therapy (DBT) shows a moderate effect size in reducing self-harm (Hedges' g = -0.622) and induces neuroplastic changes. Mentalization-Based Therapy (MBT) reduces suicide attempts, though social functioning often remains impaired even in long-term follow-up. Conclusions. Specialized psychotherapies effectively stabilize acute symptoms, but a clear gap persists between symptom control and functional recovery. Future research should adopt complex dynamic systems perspectives and prioritize outcomes reflecting social integration and quality of life.
- 27 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Open AccessNon-Suicidal Self-Injury (NSSI) in Borderline Personality Disorder: Dynamic Mechanisms, Cascading Models, and Psychosocial Outcomes in the Context of Specialist Interventions
Background. Non-suicidal self-injury (NSSI) occurs in 69-90% of women with borderline personality disorder (BPD) and represents a critical diagnostic criterion and therapeutic challenge. Despite its high prevalence and clinical significance, the dynamic psychological and neurobiological mechanisms underlying NSSI remain incompletely understood, and a substantial gap persists between acute symptom reduction and long-term psychosocial recovery. Aim. This study reviews NSSI in BPD, focusing on: identification of proximal psychological mechanisms and developmental factors influencing NSSI risk, and assessment of specialized therapeutic approaches' effectiveness in reducing NSSI and achieving sustained psychosocial functioning. Materials and Methods. A literature review was conducted using databases (PubMed, PsycINFO, and Google Scholar) for articles up to November 2025. Inclusion criteria focused on peer-reviewed studies examining NSSI in BPD populations using validated assessment tools. Results. Neuroimaging demonstrates that NSSI produces immediate amygdala deactivation, providing neurobiological reinforcement for this behavior. The Emotional Cascade Model identifies rumination instability and emotion differentiation deficits as key triggers for NSSI episodes. Childhood trauma dysregulates the HPA axis and correlates with functional deficits. Dialectical Behavior Therapy (DBT) shows a moderate effect size in reducing self-harm (Hedges' g = -0.622) and induces neuroplastic changes. Mentalization-Based Therapy (MBT) reduces suicide attempts, though social functioning often remains impaired even in long-term follow-up. Conclusions. Specialized psychotherapies effectively stabilize acute symptoms, but a clear gap persists between symptom control and functional recovery. Future research should adopt complex dynamic systems perspectives and prioritize outcomes reflecting social integration and quality of life.
- Open Access
- 23 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS
The escalating global burden of mental health disorders, coupled with the stagnation of innovation in traditional monoaminergic pharmacotherapy (e.g., SSRIs), has precipitated a critical need for novel therapeutic paradigms. This article presents a comprehensive systematic review of the so-called "Psychedelic Renaissance," focusing on the clinical resurgence of classical serotonergic hallucinogens: psilocybin and Lysergic Acid Diethylamide (LSD). The review adopts an interdisciplinary structure to evaluate the efficacy, safety, and societal implications of these compounds. Firstly, the paper traces the historical evolution of psychedelics from indigenous sacramental use, through the research proliferation of the 1950s, to the prohibitive legislation of the late 20th century. Secondly, it delineates the neurobiological mechanisms of action, specifically 5-HT2A receptor agonism and the disintegration of the Default Mode Network (DMN), which correlates with the alleviation of rigid cognitive patterns in depression and anxiety. Thirdly, the review synthesizes data from contemporary clinical trials demonstrating significant therapeutic potential in Treatment-Resistant Depression (TRD), end-of-life existential distress, and substance use disorders. Unlike standard pharmacological reviews, this paper also analyzes the distinct psychotherapeutic framework ("set and setting"), integration processes, and socio-economic factors, including cost-effectiveness and access equity. The findings suggest that psychedelic-assisted therapy represents a transformative shift from chronic symptom management to rapid, episodic curative interventions, provided that regulatory and ethical challenges are adequately addressed.
- 23 January 2026
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (1(49))
Open AccessTHE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS
The escalating global burden of mental health disorders, coupled with the stagnation of innovation in traditional monoaminergic pharmacotherapy (e.g., SSRIs), has precipitated a critical need for novel therapeutic paradigms. This article presents a comprehensive systematic review of the so-called "Psychedelic Renaissance," focusing on the clinical resurgence of classical serotonergic hallucinogens: psilocybin and Lysergic Acid Diethylamide (LSD). The review adopts an interdisciplinary structure to evaluate the efficacy, safety, and societal implications of these compounds. Firstly, the paper traces the historical evolution of psychedelics from indigenous sacramental use, through the research proliferation of the 1950s, to the prohibitive legislation of the late 20th century. Secondly, it delineates the neurobiological mechanisms of action, specifically 5-HT2A receptor agonism and the disintegration of the Default Mode Network (DMN), which correlates with the alleviation of rigid cognitive patterns in depression and anxiety. Thirdly, the review synthesizes data from contemporary clinical trials demonstrating significant therapeutic potential in Treatment-Resistant Depression (TRD), end-of-life existential distress, and substance use disorders. Unlike standard pharmacological reviews, this paper also analyzes the distinct psychotherapeutic framework ("set and setting"), integration processes, and socio-economic factors, including cost-effectiveness and access equity. The findings suggest that psychedelic-assisted therapy represents a transformative shift from chronic symptom management to rapid, episodic curative interventions, provided that regulatory and ethical challenges are adequately addressed.
- Open Access
- 22 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Therapeutic potential of curcumin in dermatological conditions: mechanisms, clinical evidence and safety considerations
Curcumin, a pleiotropic polyphenol derived from Curcuma longa, has gained considerable interest as a potential adjuvant therapy in dermatology due to its anti-inflammatory, antioxidant, antimicrobial and immunomodulatory properties. Preclinical studies demonstrate that curcumin modulates key molecular pathways involved in skin disease, including NF-κB, JAK–STAT, MAPK and Nrf2 signalling, affecting keratinocytes, fibroblasts, melanocytes, sebocytes and cutaneous immune cells. These findings have led to an increasing number of clinical studies investigating oral and topical curcumin, novel formulations and photodynamic applications across various dermatological conditions, such as psoriasis, atopic dermatitis, acne, pigmentary disorders, chronic wounds and photoaging. Clinical evidence suggests potential benefit as an adjunct to standard therapy in psoriasis, inflammatory and pruritic dermatoses, limited vitiligo and selected wound-healing settings, while data for cosmetic and infectious indications remain preliminary. Overall, curcumin shows a favourable safety profile, with mostly mild gastrointestinal or local adverse effects, though emerging reports of hepatotoxicity and drug interactions warrant caution with high-dose or long-term systemic use. Its clinical translation is limited by poor bioavailability, heterogeneous formulations, small and methodologically weak trials and lack of outcome standardisation. This narrative review summarises current mechanistic and clinical evidence, highlights limitations and identifies priorities for future research to better define curcumin’s role in modern dermatology.
- 22 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Open AccessTherapeutic potential of curcumin in dermatological conditions: mechanisms, clinical evidence and safety considerations
Curcumin, a pleiotropic polyphenol derived from Curcuma longa, has gained considerable interest as a potential adjuvant therapy in dermatology due to its anti-inflammatory, antioxidant, antimicrobial and immunomodulatory properties. Preclinical studies demonstrate that curcumin modulates key molecular pathways involved in skin disease, including NF-κB, JAK–STAT, MAPK and Nrf2 signalling, affecting keratinocytes, fibroblasts, melanocytes, sebocytes and cutaneous immune cells. These findings have led to an increasing number of clinical studies investigating oral and topical curcumin, novel formulations and photodynamic applications across various dermatological conditions, such as psoriasis, atopic dermatitis, acne, pigmentary disorders, chronic wounds and photoaging. Clinical evidence suggests potential benefit as an adjunct to standard therapy in psoriasis, inflammatory and pruritic dermatoses, limited vitiligo and selected wound-healing settings, while data for cosmetic and infectious indications remain preliminary. Overall, curcumin shows a favourable safety profile, with mostly mild gastrointestinal or local adverse effects, though emerging reports of hepatotoxicity and drug interactions warrant caution with high-dose or long-term systemic use. Its clinical translation is limited by poor bioavailability, heterogeneous formulations, small and methodologically weak trials and lack of outcome standardisation. This narrative review summarises current mechanistic and clinical evidence, highlights limitations and identifies priorities for future research to better define curcumin’s role in modern dermatology.
- Open Access
- 22 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Aerobic Exercise as an Essential Component of Non-Pharmacological Management for Metabolic Syndrome - A Review
Background. Metabolic Syndrome (MetS) is a prevalent cluster of conditions that significantly increases the risk of cardiovascular disease and type 2 diabetes mellitus. Lifestyle modification is universally recognized as the primary therapeutic strategy, with aerobic exercise playing a crucial role in improving metabolic health and reducing mortality risks in affected populations. Aim. This review synthesizes current evidence on the efficacy and mechanisms of aerobic exercise as a fundamental non-pharmacological strategy for managing Metabolic Syndrome (MetS). Material and methods. A search of major databases (2015–2025) was performed, focusing on systematic reviews and RCTs. Keywords included "Metabolic Syndrome," "aerobic exercise," "insulin resistance," "dyslipidemia," and "exercise prescription." Results. Regular aerobic exercise improves cardiometabolic risk factors independently of significant weight loss. It enhances insulin sensitivity via GLUT4 translocation, optimizes the lipid profile (reducing triglycerides, increasing HDL), and reduces visceral adiposity and inflammation. Additionally, High-Intensity Interval Training (HIIT) is highlighted as a potent strategy, often offering superior efficacy to moderate-intensity continuous training (MICT). Conclusions. Aerobic exercise is an essential component of MetS management. Professionals should prioritize individualized prescriptions, incorporating both MICT and HIIT, to effectively mitigate cardiometabolic risk and improve patient health.
- 22 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 50
Open AccessAerobic Exercise as an Essential Component of Non-Pharmacological Management for Metabolic Syndrome - A Review
Background. Metabolic Syndrome (MetS) is a prevalent cluster of conditions that significantly increases the risk of cardiovascular disease and type 2 diabetes mellitus. Lifestyle modification is universally recognized as the primary therapeutic strategy, with aerobic exercise playing a crucial role in improving metabolic health and reducing mortality risks in affected populations. Aim. This review synthesizes current evidence on the efficacy and mechanisms of aerobic exercise as a fundamental non-pharmacological strategy for managing Metabolic Syndrome (MetS). Material and methods. A search of major databases (2015–2025) was performed, focusing on systematic reviews and RCTs. Keywords included "Metabolic Syndrome," "aerobic exercise," "insulin resistance," "dyslipidemia," and "exercise prescription." Results. Regular aerobic exercise improves cardiometabolic risk factors independently of significant weight loss. It enhances insulin sensitivity via GLUT4 translocation, optimizes the lipid profile (reducing triglycerides, increasing HDL), and reduces visceral adiposity and inflammation. Additionally, High-Intensity Interval Training (HIIT) is highlighted as a potent strategy, often offering superior efficacy to moderate-intensity continuous training (MICT). Conclusions. Aerobic exercise is an essential component of MetS management. Professionals should prioritize individualized prescriptions, incorporating both MICT and HIIT, to effectively mitigate cardiometabolic risk and improve patient health.
- Open Access
- 10 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 87, 67416
Paediatric Stroke: Diagnostic Strategies and Therapeutic Dillemas
Background. Paediatric arterial ischemic stroke is a potentially disabling neurological condition that remains underrecognized due to its rarity and atypical clinical presentation. Diagnosis in children is often delayed because of heterogeneous symptoms and differences in stroke mechanisms compared with adults. Despite advances in neuroimaging and acute reperfusion therapies, evidence-based paediatric-specific diagnostic and treatment strategies remain limited. Aim. This review aimed to summarise current evidence regarding the epidemiology, pathophysiology, diagnostic approach, and management of acute ischemic stroke in the paediatric population. Material and methods. A narrative review of the literature was conducted using structured searches of PubMed, Google Scholar, and clinical guideline repositories. Articles published between 2015 and 2025 were included, comprising original studies, systematic reviews, meta-analyses, and international clinical guidelines focusing on risk factors, clinical presentation, neuroimaging, acute treatment, and secondary prevention. Results. Paediatric stroke differs substantially from adult stroke in etiology, clinical features, and outcomes. The most common causes include cerebral arteriopathies, congenital heart disease, infections, and haematological disorders such as sickle cell disease. Magnetic resonance imaging is the diagnostic modality of choice, with diffusion-weighted imaging and vessel wall imaging improving diagnostic accuracy. Intravenous thrombolysis and mechanical thrombectomy may be feasible and relatively safe in selected paediatric patients; however, high-quality evidence remains limited. Conclusion. Paediatric ischemic stroke remains a diagnostic and therapeutic challenge. Delayed recognition and heterogeneous mechanisms continue to limit optimal management. Further studies are needed to develop evidence-based paediatric guidelines and improve acute and long-term outcomes.
- 10 January 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 87, 67416
Open AccessPaediatric Stroke: Diagnostic Strategies and Therapeutic Dillemas
Background. Paediatric arterial ischemic stroke is a potentially disabling neurological condition that remains underrecognized due to its rarity and atypical clinical presentation. Diagnosis in children is often delayed because of heterogeneous symptoms and differences in stroke mechanisms compared with adults. Despite advances in neuroimaging and acute reperfusion therapies, evidence-based paediatric-specific diagnostic and treatment strategies remain limited. Aim. This review aimed to summarise current evidence regarding the epidemiology, pathophysiology, diagnostic approach, and management of acute ischemic stroke in the paediatric population. Material and methods. A narrative review of the literature was conducted using structured searches of PubMed, Google Scholar, and clinical guideline repositories. Articles published between 2015 and 2025 were included, comprising original studies, systematic reviews, meta-analyses, and international clinical guidelines focusing on risk factors, clinical presentation, neuroimaging, acute treatment, and secondary prevention. Results. Paediatric stroke differs substantially from adult stroke in etiology, clinical features, and outcomes. The most common causes include cerebral arteriopathies, congenital heart disease, infections, and haematological disorders such as sickle cell disease. Magnetic resonance imaging is the diagnostic modality of choice, with diffusion-weighted imaging and vessel wall imaging improving diagnostic accuracy. Intravenous thrombolysis and mechanical thrombectomy may be feasible and relatively safe in selected paediatric patients; however, high-quality evidence remains limited. Conclusion. Paediatric ischemic stroke remains a diagnostic and therapeutic challenge. Delayed recognition and heterogeneous mechanisms continue to limit optimal management. Further studies are needed to develop evidence-based paediatric guidelines and improve acute and long-term outcomes.